4 terminated, 2 completed. 5 Phase 1, 4 Phase 2, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Terminated 4, Completed 1 |
| Phase 2 | 4 | Terminated 3, Completed 1 |
| Early Phase 1 | 1 | Completed 1 |
Follow TAK-981: new trials by email Literature Review of TAK-981 trials Research Report on TAK-981
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Absorption, Distribution, Metabolism, Excretion (ADME) Study of [14C]Subasumstat in Adults With Advanced or Metastatic Solid Tumors [14C] Subasumstat, Subasumstat - Solid Tumors | Phase 1 | Terminated | Takeda | 3 | 2023-11-14 | 2025-10-06 |
| A Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myeloma (RRMM) TAK-981, Mezagitamab, Daratumumab and Hyaluronidase-fihj - Relapsed and/or Refractory Multiple Myeloma (RRMM) | Phase 1 / Phase 2 | Terminated | Takeda | 27 | 2021-04-20 | 2024-10-02 |
| Intratumoral Microdosing of TAK-981 in Head and Neck Cancer TAK-981, Cetuximab, Avelumab - Head and Neck Cancer | Early Phase 1 | Completed | Presage Biosciences | 12 | 2020-10-07 | 2022-07-29 |
| A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors TAK-981, Pembrolizumab - Advanced or Metastatic Solid Tumors | Phase 1 / Phase 2 | Completed | Takeda | 161 | 2020-08-17 | 2025-12-10 |
| A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma TAK-981, Rituximab - Lymphoma, Non-Hodgkin | Phase 1 / Phase 2 | Terminated | Takeda | 38 | 2019-10-15 | 2024-06-14 |
| A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System TAK-981 - Neoplasms, Lymphoma | Phase 1 / Phase 2 | Terminated | Takeda | 109 | 2018-10-01 | 2024-11-19 |
Head and Neck Neoplasms (1) · Hematologic Neoplasms (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Takeda (5) · Presage Biosciences (1)
United States (5) · Canada (2) · China (2) · Japan (2) · Brazil (1) · Croatia (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Latvia (1) · Lithuania (1) · Poland (1) · Spain (1) · Switzerland (1)
2023 (1)